Head-to-head · WeighScore
Bayan Health vs Strut Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 74.6/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bayan Health | Strut Health |
|---|---|---|
| WeighScore | 74.6/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #65 | #28 |
| Semaglutide | $129/mo (billed monthly against a protocol that ships three months at a time) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $149/mo (billed monthly against a protocol that ships three months at a time) | From $199/mo either route |
| Coverage | All 50 states (claimed; no list published) | 49 states (not Arkansas) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #65 · C
Strengths
- Both product pages state the price holds at every dose, so the figure does not climb as titration does
- Sells oral drops and microdose tiers below the standard injectable rate, and prices oral orforglipron tablets openly at $269 a month
- Names its clinical network, MD Integrations, and its founding physician
- Publishes an itemized fee table for consultations, follow-ups and quarterly clinical reviews rather than leaving them unpriced
- Ships free, and the medication cost is stated as included in the monthly figure
What to consider
- The monthly bill is not a monthly commitment: the Terms require opting out at least fifteen days before the next protocol cycle, and the payment obligation covers the whole two- to three-month protocol shipped
- The refund policy opens “ALL SALES ARE FINAL” and consultations are non-refundable
- The homepage says medication pricing depends on a personalized treatment plan while the product pages say the price is flat at every dose
- The FAQ says service is available nationwide, the Terms say it may not be available in all states, and no list is published
- No pharmacy is named — the site states only that it uses licensed 503A and 503B pharmacies
- No legal entity, entity suffix or street address is published anywhere on the site
- The transparent-pricing table still contains an unedited placeholder row reading “Service name $20”
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
What to consider
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring program
- Compounded only, with no brand-name lane
- Not available in Arkansas
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.